1.Why Immunology Is the Toughest Launch Environment in U.S. Pharma In 2024, immunology accounted for four of … Data-Driven Messaging for Immunology Product Launches in U.S. Pharma MarketingRead more
Immunology
How Johnson & Johnson Maintains Its Fourth-Place Global Position as Oncology and Immunology Drive Growth Against Biosimilar Pressures
Leadership in biopharma demands the ability to build new revenue engines while older franchises decline. Many … How Johnson & Johnson Maintains Its Fourth-Place Global Position as Oncology and Immunology Drive Growth Against Biosimilar PressuresRead more